BioAtla, Inc. (BCAB)
OTC: BCAB · Biological Products, (No Diagnostic Substances) · San Diego, CA · filing with the SEC since 2020
Filings
216 filings since 2017 beside 293 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026Due nextNon-accelerated filer and smaller reporting company
10-Q
Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by Nov 14, 2026
10-K
Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Mar 31, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 90 days after the quarter ended. The proxy statement was last filed Jun 3, 2026.
Filings a yearinsider forms included
4864119107646245
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 6 times in the last 36 months, the newest Sep 29, 2026.Listing warning from its exchange (8-K item 3.01): 4 times in the last 36 months, the newest Aug 28, 2026.SEC letters: 2 in the last 36 months, the newest May 12, 2025.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Oct 20, 2026
8-K items 1.01, 1.02, 3.02, 9.01
Major agreement signed; Major agreement ended; Shares sold without registration · Current report
Oct 15, 2026
Mar 31, 2026
8-K items 2.02, 7.01
Results released; Investor disclosure (Regulation FD) · Current report
Mar 23, 2026
8-K items 5.02, 5.07
Officer or director change; Shareholder vote · Current report
Mar 17, 2026
Mar 2, 2026
8-K items 2.02, 2.05, 5.02, 7.01, 8.01, 9.01
Results released; Exit or restructuring costs; Officer or director change; Investor disclosure (Regulation FD); Other event · Current report
Feb 24, 2026
Feb 6, 2026
8-K items 3.01, 7.01
Listing warning from its exchange; Investor disclosure (Regulation FD) · Current report
Jan 30, 2026
8-K items 5.03, 5.07, 7.01, 8.01, 9.01
Charter, bylaw or fiscal-year change; Shareholder vote; Investor disclosure (Regulation FD); Other event · Current report
Jan 26, 2026
Jan 12, 2026
8-K items 3.02, 5.03, 5.07, 8.01, 9.01
Shares sold without registration; Charter, bylaw or fiscal-year change; Shareholder vote; Other event · Current report
Jan 9, 2026
Dec 31, 2025
8-K items 1.01, 3.02, 7.01, 9.01
Major agreement signed; Shares sold without registration; Investor disclosure (Regulation FD) · Current report
Dec 30, 2025
Nov 21, 2025
8-K items 1.01, 2.03, 9.01
Major agreement signed; New debt or obligation taken on · Current report
Nov 20, 2025
40 of 216 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.